Mutation Detection Kits in Genome Editing Market Size [2031]

Report Description

Mutation Detection Kits in Genome Editing Market Outlook 2031

The global mutation detection kits in genome editing market size was USD 174.17 Bn in 2022 and is likely to reach USD 726.64 Bn by 2031, expanding at a CAGR of 17.2% during 2023–2031. Increasing demand for targeted medical treatments and the growing number of people suffering from congenital diseases are expected to drive the market.

Increasing awareness regarding gene therapy and technological advancements in biotechnology are expected to drive the mutation detection kits in the genome editing market during the forecast period. Every individual requires a different set of medical treatments to gain maximum health benefits. This directly affects the market growth, as the mutation detection kits help identify changes in the genetic material of patients to personalize their treatments. Furthermore, the increasing prevalence of cancer is driving the market. For instance,

• According to the report published by the WHO on February 3, 2022, cancer is the leading cause of death worldwide. In 2022, about 10 million deaths were caused by cancer across the world.

Get Free Sample Report

Mutation detection kits are laboratory test kits that track mutant genes by performing genetic disease diagnostics.  They use technologies such as CRISPR, TALEN, and others that are dedicated to detecting, cutting, and editing DNA sequence alterations. They ensure precise editing of the genome that enhances the quality of life of patients.

Advancements in biotechnology are paving the way for new and versatile gene editing platforms. These platforms identify, cut, and edit faulty gene sequences, and replace them with healthy genes. This corrects the genetic information and prevents transmission of the congenital disease to future generations. 

The COVID-19 pandemic boosted the market, due to the increasing demand for mutation kits for advanced studies on the virus. The development of COVID vaccine was crucial throughout the pandemic. In the latter half of the pandemic period, COVID-19 detection tests such as RTPCR were developed, which helped governments decide on the travel restrictions. They also helped study the viral genome and learn the host response.

Impact of Artificial Intelligence (AI) in Mutation Detection Kits in Genome Editing Market

The use of artificial intelligence is likely to provide substantial propulsion to the mutation detection kits in the genome editing market. This is attributed to the accuracy of AI in analyzing patterns. AI accurately identifies the faulty gene pattern, which indicates genetic mutation of the patient.

The predictive nature of AI, when incorporated with accurate machine learning algorithms, help CRISPR to target the right DNA or RNA strand, which minimizes the scope of serious errors, which is expected to create immense growth opportunities in the market.

Mutation Detection Kits in Genome Editing Market Dynamics

Get Free Sample Report

Major Drivers

Increasing demand for personalized medicine is driving the market. Personalized medicine identifies the detailed genetic profiles of patients to personalize their medical treatment.

It helps identify the problematic gene. It is highly beneficial in exploring biomarkers to identify and treat diseases, such as cancer, and other genetic conditions, such as heart disorders, mental disorders, type 2 diabetes, and others. The increasing prevalence of chronic diseases across the world is expected to drive the market.  For instance,

• According to the report published by WHO on September 16, 2023, chronic diseases account for about 17.9 million deaths worldwide. This includes diseases, such as cancer, heart disease, and diabetes.

Existing Restraints

Lack of skilled professionals to perform the necessary procedures is likely to hamper the market growth. Genetic editing requires trained professionals to identify and target the right genes to avoid complications. Furthermore, the lack of awareness regarding gene therapy and targeted medical treatments is likely to hinder the market during the assessment period.

Emerging Opportunities

Increasing applications of gene editing in agriculture are expected to drive the market. Editing the genes of crops to make them insect-resistant or immune to certain plant diseases is a common practice.

This improves the quality of crop yield and reduces the scope of crop damage, which benefits the farmers. Gene editing is expected to provide immense opportunities for market growth in the coming years, due to technological advancements in biotechnology.

Scope of the Mutation Detection Kits in Genome Editing Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Mutation Detection Kits in Genome Editing Market Segment Insights

Technology Segment Analysis

Based on technology, the mutation detection kits in the genome editing market is divided into ZFN, CRISPR/Cas9, TALENs/MegaTALs, and meganucleases. The CRISPR/Cas9 segment is projected to dominate the market during the projection period, due to its high precision efficiency while editing the genome.

Clustered Regularly Interspaced Short Palindromic Repeats or CRISPR technology uses the Cas9 enzyme, released by CRISPR, to cut the problematic gene sequence in the DNA. Presently, with the help of technological advancements, researchers activate or deactivate particular gene sequences. The technology is useful in conducting the research and treatment of chronic diseases, such as type 2 diabetes, heart arrhythmias, and cancer.

The key players in the market are heavily investing in CRISPR-based applications. Increasing demand for targeted gene therapies and the rising popularity of personalized medicine in the healthcare industry worldwide are expected to drive the segment in the coming years. Furthermore, the CRISPR technology also helps in crop improvement in agriculture.

Get Free Sample Report

End-user Segment Analysis

Based on end-user, the global market is segregated into academic and research institutes, pharmaceutical companies, biotechnology companies, and clinical laboratories. The academic and research institutes segment is projected to expand at a high CAGR during the forecast period, owing to the increasing research and development activities for clinical diagnostics.

The rising awareness regarding personalized medicine plays a crucial role in the growing number of healthcare institutions that provide targeted treatment facilities to their patients worldwide.

Increasing global incidences of cancer is driving the market, as it encourages players the market players to invest in studies and research to find techniques to treat cancer.

Moreover, the rising awareness about preventing the transfer of congenital diseases, such as clubfoot, heart defects, hernia, and HIV, from parents to the children is expected to drive the market.

Regional Outlook

In terms of region, the global mutation detection kits in the genome editing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to hold a major share of the market in terms of revenue during the forecast period, owing to the advanced healthcare infrastructure in the region.

Countries such as the US and Canada are considered as global leaders in providing advanced care facilities to their patients. Presence of international healthcare regulatory bodies such as the National Institute of Health (NIH) and the Center for Disease Control and Prevention (CDC) encourages healthcare providers to meet the standards of patient care.

Majority of deaths in the region are caused by chronic diseases, such as cardiovascular diseases, diabetes, hypertension, and others, which is expected to drive the market in the region in the coming years. For instance,

• According to data published by the CDC on May 15, 2023, about 6,95000 people in the US died due to heart disease in 2021.

Asia Pacific is expected to dominate the market during the projection period, owing to the increasing popularity of targeted therapy in the region. The region consists of countries such as Australia, Hong Kong, Singapore, Japan, and Taiwan with advanced healthcare infrastructure that focuses on providing the ultimate patient care. Developing economies such as India, China, Thailand, and others have progressive healthcare systems.

Governments of the countries in the region are focused on providing advanced healthcare facilities to the patients and making them accessible to people. Furthermore, the rising prevalence of cancer is expected to drive the market.  For instance,

• According to the report published by the NIH in December 2022, Asia accounted for about 49.3% of the global cancer incidence in 2022, where colorectal, lung, stomach, and liver cancers were prevalent among victims.

  Get Free Sample Report